Sign in

Trial result ·

Berberine improves diabetic foot ulcer healing after tibial transverse osteotomy by inhibiting the PDGF-B/PDGFRβ signaling pathway.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This trial tested a plant compound called berberine in people with diabetic foot ulcers. All of them were due to have a shin bone surgery called TTO. The 96 people were put into 2 groups of 48 by chance. One group got local berberine shots with the surgery. The other group got salt water shots instead. The trial was blinded, and the main check was ulcer healing at 3 months.

What they found

All 96 people stayed in the study for the full 3 months. More people in the berberine group had their ulcers heal well. This group also had better results on a leg test called ABI. Their ulcer healing rate was higher than in the salt water group. Blood signs of inflammation fell more with berberine. Fewer wound cells died in the berberine group. Levels of the PDGF-B and PDGFRβ proteins were lower. No severe harms linked to the shots were reported.

What it means for patients

The authors say berberine shots added to TTO helped ulcers heal in this trial. They tie this gain to less inflammation and fewer dying wound cells. They also tie it to lower activity of the PDGF-B pathway.

Why it is not certain yet

The trial took place at just one center. The authors say the links to cell signals are only links, not proof of cause. These links still need more lab work to check them. The abstract gives results only up to 3 months. The authors say larger trials at many centers must confirm benefit and safety.

Source

Berberine improves diabetic foot ulcer healing after tibial transverse osteotomy by inhibiting the PDGF-B/PDGFRβ signaling pathway.

PubMed · PMID 42924998

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Diabetic foot ulcer publications